Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hip fracture patients suffer less pain during spinal anesthesia prep with nerve block

NCT ID NCT07594366

Symptom relief Sponsor: Suez Canal University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a nerve block (fascia iliaca block) given before spinal anesthesia helps patients with hip or upper thigh fractures get into a comfortable position. Forty patients were randomly assigned to receive either the nerve block with bupivacaine or a placebo (salt water) injection. The researchers measured how far patients could bend their hips and how often spinal anesthesia was successful. The goal was to see if the nerve block reduces pain and makes positioning easier.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bupivacaine
What this could lead to
If it works, this could make spinal anesthesia easier and less painful for people with hip fractures, potentially improving success rates.
What could go wrong
This is a small, completed study with only 40 participants, so results may not apply to everyone. The nerve block itself carries small risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Sep 2022

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients are ASA I (American Society of Anesthesiologists physical status grade I) = normal healthy patients, ASA II (American Society of Anesthesiologists physical status grade II) = patients with mild systemic disease and no functional limitations, or ASA III (American Society of Anesthesiologists physical status grade III) = patients with moderate systemic disease and some functional limitations. * Patients having hip and/or proximal femur fractures. Exclusion Criteria: * Patient refusal to participate in the study * Patients' refusal for regional anaesthesia * Patients have other combined fractures rather than unilateral hip or proximal femur fractures. * Underlying coagulopathies. * Local infection. * Known allergy to LA. * Body mass index (BMI) more than 40 kg/m². * Heart block greater than first-degree. * Renal and hepatic dysfunction. * Neurological diseases such as Alzheimer's and dementia or apparent psychological instability.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip fracture are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hip fracture local anesthetic poisoning

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Spinal anaesthesia Spinal anaesthetic poisoning

Contacts and locations

Locations

  • Faculty of Medicine, Suez Canal University

    Ismailia, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.